Relative Bioavailability of a Fentanyl Patch
NCT00857753 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2017-03-29
Summary
Tohe purpose of this study is to demonstrate the bioequivalence of a fentanyl patch transdermal delivery system.
Conditions
Interventions
- DRUG
-
Fentanyl patch 25 ug/nr Sandoz
- DRUG
-
Duragesic
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Darin B. Brimhall, D.O. · Novum Pharmaceutical Research Services
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-09-30
- Primary Completion
- 2006-10-31
- Completion
- 2006-10-31
More Related Trials
-
Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain
NCT00237341 ·Status: COMPLETED ·Phase: PHASE4
-
Transdermal Patch CVD 2000: The Effect of Heat on Fentanyl Release From Fentanyl TDSs in Healthy Adults
NCT02486016 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain
NCT00236327 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Assess the Safety and Effectiveness of Durogesic (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Long-term Narcotic Pain Relief Therapy
NCT00271453 ·Status: COMPLETED ·Phase: PHASE3
-
A Relative Bioavailability Study of Fentanyl 25 μg/h Transdermal System
NCT00864565 ·Status: COMPLETED ·Phase: PHASE1
-
Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain
NCT00278824 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Safety of D-TRANS Fentanyl With Naltrexone in Adult Patients With Chronic Pain and Who Are Opioid Tolerant
NCT00650182 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Fentanyl Transdermal (Fentanest®)
NCT00959400 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer
NCT00269737 ·Status: COMPLETED ·Phase: PHASE3
-
Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and Pharmacokinetics
NCT00216684 ·Status: COMPLETED ·Phase: PHASE3
-
Staccato Fentanyl Single and Multidose PK
NCT00402350 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System
NCT00650117 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Fentanyl Patch in Partial Doses Than the Original
NCT01403363 ·Status: UNKNOWN ·Phase: NA
-
A 15-day Study to Assess the Safety and Clinical Utility of Duragesic (Fentanyl Transdermal Patch) in the Treatment of Children With Continuous Pain Requiring Narcotic Pain Relief Therapy
NCT00271414 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effect of Clinical Procedures on Drug Delivery of Mylan Fentanyl Transdermal System 25 µg/hr and Duragesic® 25 µg/hr
NCT00648414 ·Status: TERMINATED ·Phase: PHASE1
-
An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Cancer Participants With Inadequately Controlled Pain by Non-Narcotic Analgesics
NCT01060124 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy and Safety Study of Fentanyl in Participants With Chronic Pain
NCT00788372 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety, Dose Conversion, and Dose Individualization of Duragesic® (Fentanyl Transdermal Patch) in the Treatment of Children With Chronic Pain Requiring Narcotic Pain Relief Therapy
NCT00271466 ·Status: COMPLETED ·Phase: PHASE3
-
Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
NCT00216658 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)
NCT00279344 ·Status: COMPLETED ·Phase: PHASE3
-
Subjective Observational Study of Patients Using Transdermal Cream Medication And/Or Transdermal Patches With Or Without Oral Non-Narcotic Medications
NCT03768011 ·Status: UNKNOWN
-
Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain
NCT00685295 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement
NCT01688583 ·Status: COMPLETED
-
Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the Emergency Room
NCT03080324 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain
NCT02137525 ·Status: WITHDRAWN ·Phase: PHASE2